![](/img/cover-not-exists.png)
Randomized, Double-Blind, Placebo-Controlled, Dose-Escalating Phase I, Healthy Subjects Study of Intravenous OPN-305, a Humanized Anti-TLR2 Antibody
Reilly, M, Miller, R M, Thomson, M H, Patris, V, Ryle, P, McLoughlin, L, Mutch, P, Gilboy, P, Miller, C, Broekema, M, Keogh, B, McCormack, W, van de Wetering de Rooij, JVolume:
94
Language:
english
Journal:
Clinical Pharmacology & Therapeutics
DOI:
10.1038/clpt.2013.150
Date:
October, 2013
File:
PDF, 450 KB
english, 2013